IDEAYA Biosciences(IDYA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IDYA IDEAYA Biosciences

交易中 11-22 12:50:31 EST

27.26

+0.66

+2.48%

最高27.50	最低26.30	成交量50.06万
今开26.91	昨收26.60	日振幅4.51%
总市值23.56亿	流通市值23.32亿	总股本8,643万
成交额1,363万	换手率0.59%	流通股本8,554万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"IDYA","market":"US","secType":"STK","nameCN":"IDEAYA Biosciences","latestPrice":27.26,"timestamp":1732297826137,"preClose":26.6,"halted":0,"volume":500642,"delay":0,"floatShares":85536547,"shares":86431799,"eps":-2.338595,"marketStatus":"交易中","marketStatusCode":2,"change":0.66,"latestTime":"11-22 12:50:31 EST","open":26.905,"high":27.5,"low":26.3,"amount":13633302.712879999,"amplitude":0.045113,"askPrice":27.28,"askSize":100,"bidPrice":27.24,"bidSize":200,"shortable":3,"etf":0,"ttmEps":-2.338595,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732309200000},"adr":0,"listingDate":1558584000000,"adjPreClose":26.6,"preHourTrading":{"tag":"盘前","latestPrice":26.64,"preClose":26.6,"latestTime":"09:29 EST","volume":418,"amount":11134.171532,"timestamp":1732285799999},"postHourTrading":{"tag":"盘后","latestPrice":26.6,"preClose":26.6,"latestTime":"18:22 EST","volume":19173,"amount":510002.2,"timestamp":1732231339695},"volumeRatio":0.812704,"impliedVol":0.3584,"impliedVolPercentile":0.0397},"requestUrl":"/m/hq/s/IDYA","defaultTab":"news","newsList":[{"id":"2485444142","title":"IDEAYA生物科学盘中异动 下午盘股价大涨5.11%报26.85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485444142","media":"市场透视","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485444142?lang=zh_cn&edition=full","pubTime":"2024-11-22 03:33","pubTimestamp":1732217639,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日03时33分，IDEAYA生物科学股票出现异动，股价急速拉升5.11%。截至发稿，该股报26.85美元/股，成交量57.4201万股，换手率0.66%，振幅6.23%。IDEAYA生物科学股票所在的生物技术行业中，整体涨幅为0.37%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122033359a24bf339&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122033359a24bf339&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2484960389","title":"美国研究综述-Equifax、Microstrategy、Netflix","url":"https://stock-news.laohu8.com/highlight/detail?id=2484960389","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484960389?lang=zh_cn&edition=full","pubTime":"2024-11-19 15:10","pubTimestamp":1732000212,"startTime":"0","endTime":"0","summary":"美国研究综述-Equifax、Microstrategy、Netflix路透11月19日 - 华尔街证券分析师周二调整了对几家美国上市公司的评级和目标价，其中包括 Equifax、Microstrategy 和 Netflix。要闻  * 凯斯百货公司CASY.O：杰富瑞将目标价从 450 美元上调至 470 美元 * Equifax Inc EFX.N：摩根大通将目标价从304美元下调至283美元 * Microstrategy Inc MSTR.O：Benchmark将目标价从300美元上调至450美元 * Netflix Inc NFLX.O：杰富瑞将目标价从800美元上调至1000美元 * Palo Alto Networks Inc PANW.O：杰富瑞将目标价从400美元上调至450美元以下是路透周二报道的美国公司研究报告摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241119:nL4S3MQ0JJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LOVE","LU1670710661.SGD","LU0109394709.USD","LU1046421795.USD","LU1429558221.USD","KMPR","BK4585","CCCC","KHC","CASY","ACRS","MEOH","MOS","RDDT","WSM","BK4077","CGEM","FNV","LU2326559502.SGD","ARVN","CHPT","PANW","BK4588","MSTR","NFLX","PLUG","VRT","BK4113","LU1571399168.USD","MRNA","CPRT","RGNX","PTCT","FTNT","EHAB","CPRX","KYMR","BECN","QS","LU2249611893.SGD","FENC","LU0106261372.USD","RC","EFX","IDYA","DCOM","LU2237957902.USD","BK4107","IE00BQXX3C00.GBP"],"gpt_icon":1},{"id":"2482453060","title":"IDEAYA生物科学盘中异动 临近收盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482453060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482453060?lang=zh_cn&edition=full","pubTime":"2024-11-09 04:49","pubTimestamp":1731098956,"startTime":"0","endTime":"0","summary":"北京时间2024年11月09日04时49分，IDEAYA生物科学股票出现异动，股价快速上涨5.00%。截至发稿，该股报31.49美元/股，成交量47.7066万股，换手率0.55%，振幅5.47%。IDEAYA生物科学股票所在的生物技术行业中，整体涨幅为1.14%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109044916abaeee4f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241109044916abaeee4f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2481421839","title":"美国研究综述-BXP、Hubspot、高通公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481421839","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481421839?lang=zh_cn&edition=full","pubTime":"2024-11-07 15:07","pubTimestamp":1730963275,"startTime":"0","endTime":"0","summary":"美国研究综述-BXP、Hubspot、高通公司路透11月7日 - 华尔街证券分析师周四调整了对几家美国上市公司的评级和目标价，其中包括 BXP、Hubspot 和高通公司。* Clearwater Analytics Holdings Inc CWAN.N：摩根大通将其评级从中性上调至增持  * Hubspot Inc HUBS.N：摩根大通将目标价从560美元上调至635美元  * 高通QCOM.O：摩根大通将目标价从 195 美元上调至 200 美元 以下是路透周四报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241107:nL4S3ME0W1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL","LU1803068623.USD","IDYA","GILD","CWAN","FRSH","HUBS","LU2125909593.SGD","DAWN","GPOR","KRUS","NOG","BMBL","DV","ARMK","CTNM","BROS","KVYO","BK4528","BK4516","IE00BJJMRZ35.SGD","JKHY","LU0965509101.SGD","CPNG","MRK","IE00B4R5TH58.HKD","LNTH","APP","AZPN","BK4194","EMR","BXP","AIZ","GH","EHTH","LU1939255532.USD","COR","CLOV","ELF","HLNE","IFF","GHLD","ANSS","HCAT","LU1878469433.USD","LYFT","CRC","BK4223","CVS","ALB"],"gpt_icon":0},{"id":"2481853226","title":"IDEAYA生物科学盘中异动 下午盘股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481853226","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481853226?lang=zh_cn&edition=full","pubTime":"2024-11-05 02:00","pubTimestamp":1730743218,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日02时00分，IDEAYA生物科学股票出现异动，股价大幅上涨5.10%。截至发稿，该股报30.06美元/股，成交量35.5008万股，换手率0.42%，振幅6.75%。机构评级方面，在所有14家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体涨幅为0.02%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105020018a215a25a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105020018a215a25a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2478048429","title":"IDEAYA生物科学盘中异动 大幅上涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478048429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478048429?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:11","pubTimestamp":1730124681,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日22时11分，IDEAYA生物科学股票出现异动，股价急速上涨5.05%。截至发稿，该股报30.78美元/股，成交量32.8062万股，换手率0.39%，振幅3.55%。机构评级方面，在所有15家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体涨幅为0.49%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221121a1f26302&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028221121a1f26302&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2474192408","title":"IDEAYA生物科学盘中异动 快速上涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474192408","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474192408?lang=zh_cn&edition=full","pubTime":"2024-10-09 00:27","pubTimestamp":1728404850,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日00时27分，IDEAYA生物科学股票出现异动，股价快速拉升5.00%。截至发稿，该股报30.88美元/股，成交量34.4185万股，换手率0.41%，振幅4.52%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体涨幅为0.11%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090027309719f03b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410090027309719f03b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2472967642","title":"IDEAYA生物科学盘中异动 大幅下挫5.00%报30.12美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472967642","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472967642?lang=zh_cn&edition=full","pubTime":"2024-10-04 02:09","pubTimestamp":1727978974,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日02时09分，IDEAYA生物科学股票出现异动，股价急速跳水5.00%。截至发稿，该股报30.12美元/股，成交量39.9254万股，换手率0.47%，振幅5.21%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体跌幅为1.79%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004020934a1de2c2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004020934a1de2c2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4183","BK4139","ELAB","IDYA"],"gpt_icon":0},{"id":"2470940462","title":"IDEAYA生物科学盘中异动 下午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2470940462","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470940462?lang=zh_cn&edition=full","pubTime":"2024-09-26 02:47","pubTimestamp":1727290038,"startTime":"0","endTime":"0","summary":"北京时间2024年09月26日02时47分，IDEAYA生物科学股票出现异动，股价急速跳水5.00%。截至发稿，该股报29.80美元/股，成交量75.9541万股，换手率0.90%，振幅6.26%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体跌幅为0.55%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260247189719ca8e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409260247189719ca8e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2469260413","title":"IDEAYA生物科学盘中异动 急速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469260413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469260413?lang=zh_cn&edition=full","pubTime":"2024-09-24 23:24","pubTimestamp":1727191451,"startTime":"0","endTime":"0","summary":"北京时间2024年09月24日23时24分，IDEAYA生物科学股票出现异动，股价大幅下跌5.20%。截至发稿，该股报31.98美元/股，成交量29.6001万股，换手率0.35%，振幅5.28%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体跌幅为0.80%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242324119719c6ad&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409242324119719c6ad&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2469493565","title":"美国研究综述-好市多批发、麦凯森、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2469493565","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469493565?lang=zh_cn&edition=full","pubTime":"2024-09-24 20:39","pubTimestamp":1727181557,"startTime":"0","endTime":"0","summary":"    路透9月24日 - 华尔街证券分析师周二修改了对几家美国上市公司的评级和目标价，其中包括好市多批发公司、麦凯森和星巴克。要闻  * 好市多批发公司  ：雷蒙德-詹姆斯将其目标价从 880 美元上调至 980 美元             * First Citizens Bancshares   ：Wedbush将其评级从 \"跑赢大盘 \"下调至 \"中性\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"7f827d8c01bff99b769de6f50473596e","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014542.SGD","BHVN","SG9999001440.SGD","LU1974910355.USD","LU0417517546.SGD","LU2125909759.SGD","SN","PG","LU1548497426.USD","SHAK","DAY","BK4155","CL","SBUX","BDTX","IE00BLSP4452.SGD","REGN","CHD","COST","KVUE","LU2237438978.USD","BK4105","EQIX","LU1720051108.HKD","LU2125909593.SGD","BK4106","PBH","BFH","MCK","LU2087625088.SGD","LU1430594728.SGD","IDYA","BK4222","OKTA","PCOR","IE00BZ1G4Q59.USD","BRZE","LU2360032135.SGD","REPL","TW","LU2106854487.HKD","LU2125909916.SGD","LU1923622614.USD","LW","LU1923622291.USD","IE00B7SZLL34.SGD","ZVRA"],"gpt_icon":1},{"id":"2469083437","title":"欧洲研究综述-好市多批发、麦凯森、星巴克","url":"https://stock-news.laohu8.com/highlight/detail?id=2469083437","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469083437?lang=zh_cn&edition=full","pubTime":"2024-09-24 15:11","pubTimestamp":1727161860,"startTime":"0","endTime":"0","summary":"    路透9月24日 - 周二，证券分析师修改了对多家欧洲公司的评级和目标价，包括好市多批发公司、麦凯森和星巴克。要闻  * 好市多批发公司  ：雷蒙德-詹姆斯将目标价从880美元上调至980美元 * McKesson Corp   ：贝尔德将目标价从603美元下调至531美元 * 星巴克  ：杰富瑞将其评级从 \"持有 \"下调至 \"表现不佳\"。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BDTX","IE00B894F039.SGD","LU2125909759.SGD","ZVRA","LU2125909916.SGD","EQIX","COST","SBUX","LU2237438978.USD","BK4183","BK4504","IE00BZ1G4Q59.USD","BRZE","IE00B19Z3581.USD","PBH","TW","LU1923622291.USD","REPL","BFH","SG9999001440.SGD","CL","DAY","LU0965509010.AUD","PCOR","SN","BK4532","PG","MCK","IDYA","BHVN","BK4084","LU0251142724.SGD","LU0965509101.SGD","SHAK","LU2106854487.HKD","BK4581","LW","LU2125154778.USD","LU2242646821.SGD","IE00B19Z9Z06.USD","LU2125909593.SGD","BK4539","IE00BWXC8680.SGD","LU0689626769.HKD","OKTA","CHD","CRWD","KVUE"],"gpt_icon":1},{"id":"2469129321","title":"IDEAYA生物科学盘中异动 大幅下跌5.17%报33.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2469129321","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469129321?lang=zh_cn&edition=full","pubTime":"2024-09-23 21:50","pubTimestamp":1727099448,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日21时50分，IDEAYA生物科学股票出现波动，股价快速下挫5.17%。截至发稿，该股报33.19美元/股，成交量23.0135万股，换手率0.27%，振幅9.64%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体跌幅为0.71%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923215048ab655d35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923215048ab655d35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IDYA"],"gpt_icon":0},{"id":"2469907118","title":"BUZZ-眼癌药物中期试验结果良好，Ideaya公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2469907118","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469907118?lang=zh_cn&edition=full","pubTime":"2024-09-23 20:04","pubTimestamp":1727093097,"startTime":"0","endTime":"0","summary":"((自动化翻译由路透提供，请见免责声明 ))    9月23日 - ** 药物开发商Ideaya Biosciences  股价盘前上涨8.6%至38美元** 该公司称其药物darovasertib在一项针对葡萄膜黑色素瘤（一种眼癌）患者的中期试验中显示出积极的 (link)。 ** 称约49%的患者在试验中肿瘤缩小至少30** 截至上次收盘，股价累计下跌 1.6","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2468831505","title":"IDEAYA生物科学盘中异动 股价大涨5.24%报36.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468831505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468831505?lang=zh_cn&edition=full","pubTime":"2024-09-19 22:40","pubTimestamp":1726756805,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日22时40分，IDEAYA生物科学股票出现波动，股价急速拉升5.24%。截至发稿，该股报36.57美元/股，成交量34.6027万股，换手率0.41%，振幅4.76%。机构评级方面，在所有13家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。IDEAYA生物科学股票所在的生物技术行业中，整体涨幅为1.20%。IDEAYA生物科学公司简介：IDEAYA Biosciences Inc 是一家专注于肿瘤学的精准医疗公司，致力于发现和开发针对患者群体的靶向治疗方法，使用分子诊断方法进行选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192240059719be05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409192240059719be05&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2458160692","title":"IDEAYA生物科学2024财年第二财季实现净利润-52.77百万美元，同比减少88.94%","url":"https://stock-news.laohu8.com/highlight/detail?id=2458160692","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458160692?lang=zh_cn&edition=full","pubTime":"2024-08-12 00:11","pubTimestamp":1723392702,"startTime":"0","endTime":"0","summary":"8月12日，IDEAYA生物科学公布财报，公告显示公司2024财年第二财季净利润为-52.77百万美元，同比减少88.94%；其中营业收入为0.00美元，每股基本收益为-0.68美元。从资产负债表来看，IDEAYA生物科学总负债42.01百万美元，其中短期债务606000.00美元，资产负债比为0.24，流动比率为0.18。机构评级：截至2024年8月12日，当前有13家机构对IDEAYA生物科学目标价做出预测，其中目标均价为57.00美元，其中最低目标价为44.00美元，最高目标价为66.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120011459f2226d8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408120011459f2226d8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IDYA"],"gpt_icon":0},{"id":"2457111243","title":"IDEAYA 生物科学公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2457111243","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457111243?lang=zh_cn&edition=full","pubTime":"2024-08-08 21:52","pubTimestamp":1723125177,"startTime":"0","endTime":"0","summary":"   * IDEAYA Biosciences Inc   报告了截至6月底的季度调整后每股亏损68美分，低于去年同期的每股收益-50美分。12位分析师对该季度的平均预期是每股亏损54美分。华尔街预期为每股-63美分至-41美分。* IDEAYA Biosciences Inc公布的季度每股收益为亏损68美分。* 该公司当季亏损 5277 万美元。* IDEAYA Biosciences Inc 本季度股价上涨了 2.1%，今年迄今为止上涨了 0.8%。* 生物技术和医学研究同行的平均一致建议也是 \"强力买入\"。华尔街对 IDEAYA Biosciences Inc 的 12 个月目标价中位数为 57.50 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"IDEAYA 生物科学公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA","BK4139"],"gpt_icon":0},{"id":"2457077345","title":"IDEAYA Biosciences Inc    预计每股亏损 53 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2457077345","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457077345?lang=zh_cn&edition=full","pubTime":"2024-08-07 02:36","pubTimestamp":1722969370,"startTime":"0","endTime":"0","summary":"   * IDEAYA Biosciences Inc    在8月6日公布的截至2024年9月30日的财报中预计将出现季度收入下降。* 根据LSEG的数据，12位分析师的平均预期显示，这家总部位于加利福尼亚州旧金山南部的公司的营收将从去年同期的804万美元降至483.7万美元，降幅为39.8%。* LSEG分析师对IDEAYA生物科学公司的平均预期是每股亏损53美分。* 华尔街对 IDEAYA Biosciences Inc 的 12 个月目标价中位数为 60.00 美元，高于其最新收盘价 36.99 美元。8月6日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"IDEAYA Biosciences Inc    预计每股亏损 53 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDYA"],"gpt_icon":0},{"id":"2456281170","title":"IDEAYA生物科学盘中异动 早盘大幅下跌5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456281170","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456281170?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605504,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分，IDEAYA生物科学股票出现波动，股价大幅下跌5.11%。IDEAYA生物科学股票所在的生物技术行业中，整体跌幅为0.74%。消息层面，截至21时31分，《百奥赛图宣布与IDEAYA Biosciences就具有同类首创潜力的B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性ADC项目达成选择权和许可协议》资讯为影响IDEAYA生物科学的重要信息。IDEAYA正在将其研究和药物发现的能力应用于合成致死这类新兴的精准医疗靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213144af95a5aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213144af95a5aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PARG","IDYA","BK4023"],"gpt_icon":0},{"id":"2456716150","title":"IDEAYA生物科学盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2456716150","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456716150?lang=zh_cn&edition=full","pubTime":"2024-08-01 03:02","pubTimestamp":1722452568,"startTime":"0","endTime":"0","summary":"北京时间2024年08月01日03时02分，IDEAYA生物科学股票出现异动，股价大幅上涨5.04%。IDEAYA生物科学股票所在的生物技术行业中，整体涨幅为0.90%。消息层面，截至03时02分，《百奥赛图宣布与IDEAYA Biosciences就具有同类首创潜力的B7H3/PTK7拓扑异构酶抑制剂有效载荷双特异性ADC项目达成选择权和许可协议》资讯为影响IDEAYA生物科学的重要信息。IDEAYA正在将其研究和药物发现的能力应用于合成致死这类新兴的精准医疗靶点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030249af952963&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240801030249af952963&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PARG","IDYA","BK4139","BK4023"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ideayabio.com","stockEarnings":[{"period":"1week","weight":-0.0974},{"period":"1month","weight":-0.1198},{"period":"3month","weight":-0.3264},{"period":"6month","weight":-0.2946},{"period":"1year","weight":-0.1582},{"period":"ytd","weight":-0.2524}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"IDEAYA Biosciences, Inc.总部位于加利福尼亚州南旧金山，于2015年6月在特拉华州注册成立。该公司是一家专注于肿瘤学的精准医学公司，致力于为使用分子诊断选择的患者群体发现和开发靶向疗法。他们的方法将识别和验证翻译生物标志物的广泛能力与小分子药物发现相结合，以选择最有可能从他们正在开发的靶向治疗中受益的患者群体。他们正在将这些能力应用于多类精准医学，包括直接靶向致癌途径和合成致死性，这代表了一类新兴的精准医学靶点。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.051469},{"month":2,"riseRate":0.6,"avgChangeRate":-0.047326},{"month":3,"riseRate":0.2,"avgChangeRate":-0.114368},{"month":4,"riseRate":0.4,"avgChangeRate":0.066979},{"month":5,"riseRate":0.6,"avgChangeRate":0.211426},{"month":6,"riseRate":0.666667,"avgChangeRate":0.093237},{"month":7,"riseRate":0.5,"avgChangeRate":0.004546},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.039236},{"month":9,"riseRate":0.666667,"avgChangeRate":0.114165},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.088714},{"month":11,"riseRate":0.833333,"avgChangeRate":0.113641},{"month":12,"riseRate":0.8,"avgChangeRate":0.041356}],"exchange":"NASDAQ","name":"IDEAYA Biosciences","nameEN":"IDEAYA Biosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"IDEAYA Biosciences(IDYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供IDEAYA Biosciences(IDYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"IDEAYA Biosciences,IDYA,IDEAYA Biosciences股票,IDEAYA Biosciences股票老虎,IDEAYA Biosciences股票老虎国际,IDEAYA Biosciences行情,IDEAYA Biosciences股票行情,IDEAYA Biosciences股价,IDEAYA Biosciences股市,IDEAYA Biosciences股票价格,IDEAYA Biosciences股票交易,IDEAYA Biosciences股票购买,IDEAYA Biosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"IDEAYA Biosciences(IDYA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供IDEAYA Biosciences(IDYA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}